Elanco Animal Health Inc (ELAN) SEC Filings — 2024

Filings

• Elanco Animal Health Announces Board and Executive Changes — 8-K · Nov 12, 2024
• Elanco Animal Health Q3 2024 10-Q Filing — 10-Q · Nov 7, 2024
• Elanco Animal Health Files 8-K — 8-K · Oct 16, 2024
• Elanco Animal Health Enters Material Definitive Agreement — 8-K · Aug 13, 2024
• Elanco Animal Health Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Elanco Completes Bayer Animal Health Acquisition — 8-K · Jul 9, 2024
• Elanco Animal Health Inc SC 13G/A Filing — SC 13G/A · Jul 8, 2024
• Elanco Animal Health Enters Material Definitive Agreement — 8-K · Jul 3, 2024
• Elanco Animal Health Announces Corporate Changes and Filings — 8-K · Jun 4, 2024
• Elanco Animal Health Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 8, 2024
• Elanco Animal Health Proposes Governance Enhancements in Proxy Statement — DEF 14A · Apr 19, 2024
• Elanco Appoints New Chief Legal Officer — 8-K · Apr 1, 2024
• Elanco Files Definitive Additional Proxy Materials — DEFA14A · Feb 29, 2024
• Elanco Animal Health Files 8-K on Operations and Exit Costs — 8-K · Feb 26, 2024
• Elanco Animal Health Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Elanco Animal Health Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• PRIMECAP Boosts Elanco Stake to 10.3%, Holding 50.6M Shares — SC 13G/A · Feb 12, 2024
• Elanco Files 8-K on Material Agreement & Reg FD Disclosure — 8-K · Feb 5, 2024
• BlackRock Discloses Significant Stake in Elanco Animal Health — SC 13G · Jan 29, 2024
• Elanco Confirms NYSE Listing for Common Stock & Equity Units — 8-K · Jan 8, 2024
• Elanco Files Routine 8-K; Confirms Non-Emerging Growth Status — 8-K · Jan 2, 2024